PMID: 9423853Jan 10, 1998Paper

Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice

Infection and Immunity
Y MaJ J Weis

Abstract

Studies of mice infected with Borrelia burgdorferi have indicated that the severity of arthritis is influenced by the genetic composition of the host: the C3H mouse develops severe arthritis while BALB/c and C57BL/6 mice develop mild arthritis. In this study, the effects of increasing infectious dose on the severity of arthritis were determined in these three mouse strains. C3H/He mice developed severe arthritis at all infectious doses, with 100% infection requiring 200 spirochetes. In BALB/cAnN mice, arthritis severity was dependent on infectious dose; symptoms were mild with infection by 200 B. burgdorferi and progressively more severe with increasing infectious dose. Infection of BALB/cAnN mice with 2 x 10(4) B. burgdorferi resulted in arthritis with severity identical to that in C3H/He mice. Spirochete levels in rear ankle joints of C3H/HeJ and C3H/HeN mice were relatively high, as detected by PCR, and did not increase with infectious dose. Spirochete levels in joints from BALB/cAnN mice increased with increasing infectious dose to levels found in severely arthritic C3H/He mice. Thus, resistance to severe arthritis in BALB/cAnN mice was conditional: it could be overcome by high infectious dose and the arthritis became sever...Continue Reading

References

Nov 1, 1992·The American Journal of Tropical Medicine and Hygiene·S W BartholdA L Smith
Aug 1, 1992·The American Journal of Tropical Medicine and Hygiene·A L ArmstrongD S Beck
Jul 1, 1990·The Journal of Infectious Diseases·S W BartholdK D Moody
May 1, 1990·The Journal of Clinical Investigation·A SzczepanskiH B Fleit
May 1, 1989·Infection and Immunity·L E Comstock, D D Thomas
Jun 18, 1982·Science·W BurgdorferJ P Davis
Sep 1, 1995·The Journal of Infectious Diseases·S W Barthold, M de Souza
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·T G SchwanP A Rosa
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·K SukE Fikrig
Mar 1, 1995·The Journal of Experimental Medicine·J E Matyniak, S L Reiner
Oct 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A P van DamJ Dankert
Nov 1, 1993·Infection and Immunity·S W Barthold, L K Bockenstedt
Feb 15, 1996·The Journal of Clinical Investigation·J AnguitaE Fikrig

❮ Previous
Next ❯

Citations

Jul 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Charles R BrownChristie M Loiacono
Jun 14, 2003·Vector Borne and Zoonotic Diseases·Guiqing Wang
May 24, 2005·Infection and Immunity·Mireia Guerau-de-ArellanoBrigitte T Huber
Nov 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·John J LazarusR Mark Wooten
Apr 29, 2009·Infection and Immunity·Kit TillyPatricia A Rosa
Nov 28, 2008·Arthritis and Rheumatism·Bettina Panagiota IliopoulouBrigitte T Huber
Dec 20, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·F Lynn SondereggerJanis J Weis
Apr 15, 2015·Proceedings of the National Academy of Sciences of the United States of America·Alvaro ToledoJorge L Benach
Nov 10, 2015·PloS One·Beth L DumontNadia D Singh
May 23, 2003·Infection and Immunity·Timothy R CrotherMichael A Lovett
Jan 13, 2004·Clinical and Diagnostic Laboratory Immunology·Erik L MunsonRonald F Schell
Dec 26, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·R Mark WootenJanis J Weis
Mar 26, 2004·Nature Reviews. Immunology·Allen C Steere, Lisa Glickstein
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hillary CrandallJanis J Weis
Jul 9, 2008·The Journal of Parasitology·Nordin S ZeidnerMarc C Dolan
Apr 2, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gennady G YegutkinMatti K Viljanen
Sep 17, 2008·Immunopharmacology and Immunotoxicology·Bettina Panagiota Iliopoulou, Brigitte T Huber
Jul 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C R Brown, S L Reiner
Feb 21, 2002·Infection and Immunity·Melissa R PotterJanis J Weis
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amy M BeckerNicolai S C van Oers
Apr 28, 2004·Medical Microbiology and Immunology·Sharon LedererMarkus M Simon
Jun 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Guiqing WangIra Schwartz
Mar 26, 2003·Vector Borne and Zoonotic Diseases·N S ZeidnerJ Piesman
Mar 31, 2012·Clinical & Developmental Immunology·Erik MunsonRonald F Schell
Oct 18, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Lars RåbergAndrew F Read
May 23, 2009·PLoS Pathogens·Joppe W R HoviusTom van der Poll
Jun 3, 2009·The Journal of Biological Chemistry·Victoria A BlahoEdward A Dennis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.